Moderna Spikevax vaccine approved for children 6-11 years

  The ATAGI approval of Moderna Spikevax for the primary vaccination of children 6-11 years provides more options for families and pharmacists. Read the ATAGI statement. Key points include: There is NO paediatric formulation. It is the same Moderna Spikevax formulation used for patients 12 years and older. The dose is 50µg (0.25ml) for children 6-11 years i.e. HALF the primary dose for patients 12 years and over. The dose is the same as the booster dose (50µg – 0.25ml) approved for people 18 years and over (at time of publication). The recommended schedule for Modern…